Lobbying client

MOLECULAR INSIGHT PHARMACEUTICALS

Biopharmaceutical Company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
11
Filed by
2
Reported in-house
—
Reported by firms
$200,750

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2007 to 2010

Filings

11 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination
1st Quarter 2010
O'NEILL AND ASSOCIATES $20,000 reported
1st Quarter - Reportreplaced
1st Quarter 2010
O'NEILL AND ASSOCIATES $20,000 reported
4th Quarter - Amendment
4th Quarter 2009
O'NEILL AND ASSOCIATES $30,000 reported
4th Quarter - Reportreplaced
4th Quarter 2009
O'NEILL AND ASSOCIATES $30,000 reported
Registration
2nd Quarter 2009
O'NEILL AND ASSOCIATES — reported
4th Quarter - Termination
4th Quarter 2008
JEFFREY J. KIMBELL & ASSOCIATES, INC. — reported
3rd Quarter - Report
3rd Quarter 2008
JEFFREY J. KIMBELL & ASSOCIATES, INC. $27,000 reported
2nd Quarter - Report
2nd Quarter 2008
JEFFREY J. KIMBELL & ASSOCIATES, INC. $11,250 reported
1st Quarter - Report
1st Quarter 2008
JEFFREY J. KIMBELL & ASSOCIATES, INC. $22,500 reported
Year-End Report
Year-End 2007
JEFFREY J. KIMBELL & ASSOCIATES, INC. $45,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
JEFFREY J. KIMBELL & ASSOCIATES, INC. 6 $150,750
O'NEILL AND ASSOCIATES 2 $50,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 4
Pharmacy PHA 2
Budget/Appropriations BUD 2
Science/Technology SCI 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.